Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4081 - 4088 of 12011 results
Antitrust Division Gives Thumbs Up to Pork Farmers’ Collaboration on Hog Euthanasia
May 18, 2020| Blog| Viewpoint
Part Nine of the COVID-19 Roadmap Series: Ensuring Compliance – Leave Management
May 18, 2020| Blog| Viewpoint
Better Early Than Never: PTAB Confirms Willingness to Deny Institution In Light of Advanced State of Parallel Litigation
May 18, 2020| Blog| Viewpoint
Massachusetts’ Reopening Advisory Board Releases Reopening Report
May 18, 2020| Blog| Viewpoint
Form I-9 Requirements Flexibility Extended for 30 Days
May 18, 2020| Blog| Viewpoint
Part Two: To Pay, or Not to Pay (Rent) – California Landlord-Tenant Regulations During COVID-19
May 15, 2020| Blog| Viewpoint
Formation 101: Choosing an Entity and Jurisdiction
May 15, 2020| Video| Viewpoint
COVID-19: Prioritized Patent Application Examination and Patents 4 Partnerships
May 15, 2020| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|